EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Isoniazid-historical development, metabolism associated toxicity and a perspective on its pharmacological improvement

Jishnu Sankar, Anjali Chauhan, Ramandeep Singh, Dinesh Mahajan

Frontiers in Pharmacology · 19.09.2024 · 15

DOI: 10.3389/fphar.2024.1441147 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 19.09.2024. Verfasst von Jishnu Sankar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Drug Discovery, BRIC-Translational Health Science and Technology Institute, Faridabad, Haryana, India. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 159 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Biotechnology, Ministry of Science and Technology, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the extraordinary anti-tubercular activity of isoniazid (INH), the drug-induced hepatotoxicity and peripheral neuropathy pose a significant challenge to its wider clinical use. The primary cause of INH-induced hepatotoxicity is in vivo metabolism involving biotransformation on its terminal -NH 2 group owing to its high nucleophilic nature. The human N-acetyltransferase-2 enzyme (NAT-2) exploits the reactivity of INH’s terminal -NH 2 functional group and inactivates it by transferring the acetyl group, which subsequently converts to toxic metabolites. This -NH 2 group also tends to react with vital endogenous molecules such as pyridoxine, leading to their deficiency, a major cause of peripheral neuropathy. The elevation of liver functional markers is observed in 10%–20% of subjects on INH treatment. INH-induced risk of fatal hepatitis is about 0.05%–1%. The incidence of peripheral neuropathy is 2%–6.5%. In this review, we discuss the genesis and historical development of INH, and different reported mechanisms of action of INH. This is followed by a brief review of various clinical trials in chronological order, highlighting treatment-associated adverse events and their occurrence rates, including details such as geographical location, number of subjects, dosing concentration, and regimen used in these clinical studies. Further, we elaborated on various known metabolic transformations highlighting the involvement of the terminal -NH 2 group of INH and corresponding host enzymes, the structure of different metabolites/conjugates, and their association with hepatotoxicity or neuritis. Post this deliberation, we propose a hydrolysable chemical derivatives-based approach as a way forward to restrict this metabolism.

Schlagwörter

Stichwörter der Autor:innen

N-acetyltransferasehepatotoxicityisoniazidmetabolismperipheral neuropathyprodrug

Autor:innen und Institutionen

  • Centre for Drug Discovery, BRIC-Translational Health Science and Technology Institute, Faridabad, Haryana, India.
  • Centre for Tuberculosis Research, BRIC-Translational Health Science and Technology Institute, Faridabad, Haryana, India.
  • Department of Pharmaceutical Chemistry, Delhi Institute of Pharmaceutical Sciences and Research, New Delhi, India.

Förderung

  • Department of Biotechnology, Ministry of Science and Technology, India

Zitieren

APA

Sankar, J., Chauhan, A., Singh, R., & Mahajan, D. (2024). Isoniazid-historical development, metabolism associated toxicity and a perspective on its pharmacological improvement. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1441147

Vancouver

Sankar J, Chauhan A, Singh R, Mahajan D. Isoniazid-historical development, metabolism associated toxicity and a perspective on its pharmacological improvement. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1441147

BibTeX
@article{Sankar2024,
  author = {Sankar, Jishnu and Chauhan, Anjali and Singh, Ramandeep and Mahajan, Dinesh},
  title = {Isoniazid-historical development, metabolism associated toxicity and a perspective on its pharmacological improvement},
  journal = {Frontiers in Pharmacology},
  year = {2024},
  volume = {15},
  doi = {10.3389/fphar.2024.1441147}
}
Kostenlos starten →